Creative Medical Technology Holdings Inc (CELZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELZ | AMGN | VRTX | REGN | BMY |
| Company | Creative Medical Technology Holdings Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 4.42 | 269.18 | 397.48 | 883.20 | 45.09 |
| High | 4.50 | 276.86 | 399.31 | 897.78 | 45.38 |
| Low | 4.33 | 268.99 | 394.35 | 883.20 | 44.53 |
| Last | 4.39 | 276.58 | 396.47 | 893.96 | 44.65 |
| Change | +0.07 | +6.60 | -1.01 | +10.76 | -0.20 |
| % Change | +1.62% | +2.44% | -0.25% | +1.22% | -0.45% |
| Volume | 3,167 | 1,764,269 | 460,654 | 279,923 | 12,876,547 |
| 20-Day Average Volume | 12,643 | 2,135,449 | 924,308 | 450,898 | 13,287,761 |
| Previous Close | 4.32 | 269.98 | 397.48 | 883.20 | 44.85 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.11 | 269.63 | 400.02 | 914.68 | 49.05 |
| 20-Day Raw Stochastic | 5.93% | 65.28% | 14.53% | 19.31% | 3.11% |
| 20-Day Relative Strength | 37.76% | 51.49% | 41.03% | 37.26% | 28.61% |
| Weighted Alpha | -40.13 | +13.69 | +12.10 | +15.12 | -35.40 |
| Today's Opinion | 8% Sell | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 8% Sell | 72% Sell | 8% Buy | 8% Sell | 88% Sell |
| Last Month's Opinion | 48% Buy | 24% Buy | 56% Buy | 80% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.11% since 04/22/24 | +1.45% since 04/22/24 | -1.14% since 04/22/24 | -0.90% since 04/22/24 | -9.20% since 04/22/24 |
| Low | 4.30 on 04/26/24 | 265.72 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 4.93 on 04/23/24 | 276.36 on 04/29/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 | 49.47 on 04/23/24 |
| 1-Month | |||||
| %Chg | -15.74% since 03/28/24 | -2.98% since 03/28/24 | -5.42% since 03/28/24 | -7.32% since 03/28/24 | -17.72% since 03/28/24 |
| Low | 4.30 on 04/26/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 5.85 on 04/08/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | +2.90% since 01/29/24 | -12.00% since 01/29/24 | -9.29% since 01/29/24 | -6.67% since 01/29/24 | -10.53% since 01/29/24 |
| Low | 3.93 on 02/23/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 44.34 on 04/26/24 |
| High | 10.28 on 03/07/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +0.23% since 10/27/23 | +5.46% since 10/27/23 | +11.28% since 10/27/23 | +15.07% since 10/27/23 | -12.54% since 10/27/23 |
| Low | 3.93 on 02/23/24 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 44.34 on 04/26/24 |
| High | 10.28 on 03/07/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,861 | 144,810,784 | 102,732,288 | 96,941,800 | 90,900,144 |
| Shares Outstanding, K | 1,357 | 536,376 | 258,459 | 109,762 | 2,026,759 |
| Annual Sales | 10,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -5,290,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 10,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,477,000,000 |
| Last Quarter Net Income | -1,450,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | 1,762,000,000 |
| 60-Month Beta | 2.21 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.21 on 03/22/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.44 | 29.59 | 23.70 | 6.08 |